CP Reports Store

Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.

CP Reports Store offers over 100 report titles that focus upon different deal types and technology or therapy areas including licensing, collaborative R&D, co-promotion, biomarkers, diagnostics, oncology, immunology all of which provide a detailed insight into the latest life science deal making trends.

Browse our reports by type to find your ideal match.

 

Our reports are updated regularly and include full coverage of the latest deals in the chosen report type.

Unsure which report to select? Contact our report analysts who will assist your decision.

Items 31-40 of 51

per page
Set Ascending Direction
  1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  2. Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  3. Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

    Learn More
  4. Global Dermatology Partnering 2014-2020: Deal trends, players and financials
    Global Dermatology Partnering 2014-2020: Deal trends, players and financials
    April 2020
    $3,495.00

    The Global Dermatology Partnering 2014-2020 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies

    Learn More
  5. Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials
    Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials
    April 2020
    $3,495.00

    The Global Central Nervous System Partnering 2014 to 2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the central nervous system (cns) partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  6. Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020
    Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.

    Learn More
  7. Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020
    Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

    Learn More
  8. Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies 

    Learn More
  9. Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies.

    Learn More
  10. Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020
    April 2020
    $3,495.00

    The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.

    Learn More

Items 31-40 of 51

per page
Set Ascending Direction